**Question:** Drug of choice in Neonatal ITP is -

A. Cyclosporine
B. Intravenous Immunoglobulin (IVIG)
C. Corticosteroids
D. Erythropoietin

**Correct Answer:** B. Intravenous Immunoglobulin (IVIG)

**Core Concept:**
The correct choice for the treatment of Neonatal Immune Thrombocytopenic Purpura (ITP) is primarily based on understanding the disease pathophysiology and its management strategies. Neonatal ITP is a primary immune-mediated thrombocytopenia in neonates characterized by low platelet count leading to increased risk of bleeding.

**Why the Correct Answer is Right:**
Intravenous Immunoglobulin (IVIG) is a suitable option for treating neonatal ITP due to its immunomodulatory properties. IVIG contains polyclonal antibodies that can suppress the activation of neonatal T cells and B cells, thereby reducing the production of anti-platelet autoantibodies. This leads to increased platelet production and elevated platelet count, reducing the bleeding risk in neonatal patients with ITP.

**Why Each Wrong Option is Incorrect:**

A. Cyclosporine: Cyclosporine is an immunosuppressive agent primarily used in organ transplantation and autoimmune disorders. Although it can suppress the immune response, its use in neonatal ITP is not as effective as IVIG due to the different pathophysiology of neonatal ITP.

B. Erythropoietin: Erythropoietin is a hormone involved in stimulating red blood cell production and is primarily used for anemia management. It does not directly target the platelet production or immune system modulation, making it an unsuitable option for treating neonatal ITP.

C. Corticosteroids: Corticosteroids are anti-inflammatory agents that can suppress the immune response to some extent. However, they might not be as effective in neonates as IVIG due to the unique pathophysiology of neonatal ITP.

**Core Concepts:**
- Neonatal ITP: Immune-mediated thrombocytopenia in neonates
- IVIG: Polyclonal antibodies from multiple donors to modulate the immune response
- Cyclosporine: Immunosuppressive agent for organ transplantation and autoimmune disorders
- Erythropoietin: Stimulates red blood cell production
- Corticosteroids: Anti-inflammatory agents for immune system modulation

**Why Each Wrong Option is Incorrect:**

A. Cyclosporine: Although it can suppress the immune system, its use in neonatal ITP is less effective than IVIG due to the distinct pathophysiology of neonatal ITP.

B. Erythropoietin: Erythropoietin is primarily involved in stimulating red blood cell production and does not directly target platelet production or immune system modulation, making it an unsuitable option for treating neonatal ITP.

C. Corticosteroids: Corticosteroids are anti-inflammatory agents that can suppress the immune system to some extent, but their efficacy in neonatal